About
Cytokine Immunotherapy
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
483
By Phase
PHASE2: 5PHASE1/PHASE2: 2
By Status
COMPLETED: 5WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT02980198Lead Sponsor
Study of IFN-K in Dermatomyositis
PHASE2Withdrawn
Started: May 3, 2017 · Completed: Dec 11, 2019
NCT02665364Lead Sponsor
Phase IIb Study of IFN-K in Systemic Lupus Erythematosus
PHASE2Terminated
185 participants
Started: Sep 23, 2015 · Completed: Feb 4, 2020
NCT01911234Lead Sponsor
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
PHASE2Completed
143 participants
Started: Sep 30, 2013 · Completed: Sep 30, 2014
NCT01291810Lead Sponsor
Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients
PHASE2Completed
66 participants
Started: Feb 28, 2011 · Completed: May 31, 2014
NCT01058343Lead Sponsor
Safety of IFNa Kinoid in Systemic Lupus Erythematosus
PHASE1/PHASE2Completed
28 participants
Started: Mar 31, 2010 · Completed: Jun 30, 2016
Locations (1)
Headquarters
Suresnes, France
Map
Loading map...